The unintended consequences of argument dilution in direct-to-consumer drug advertisements

Nature Human Behaviour

Volumn 1, Issue 11, 2017, Pages 797-802

  Sivanathan, Niro ^a   Kakkar, Hemant ^a  

^a LONDON BUSINESS SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADULT; ATTITUDE TO HEALTH; CONSUMER ATTITUDE; DECISION MAKING; DIRECT-TO-CONSUMER ADVERTIZING; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; PERCEPTION; RANDOMIZATION; UNITED STATES;

ADULT; CONSUMER BEHAVIOR; DIRECT-TO-CONSUMER ADVERTISING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; JUDGMENT; MALE; PERCEPTION; PRESCRIPTION DRUGS; RANDOM ALLOCATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85035197326     PISSN: None     EISSN: 23973374     Source Type: Journal    
DOI: 10.1038/s41562-017-0223-1     Document Type: Article

References (25)

1. Vastag, B. US aims to tighten rules on direct-to-consumer drug ads. Nat. Biotechnol. 25, 267-267 (2007).
2. Food and Drug Administration Regulatory Modernization Act of 1997, H.R. 1411, 105th Cong., 1st Sess. (1997); https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDAMA/FullTextofFDAMAlaw/default.htm
3. Mogull, S. A. Chronology of direct-to-consumer advertising regulation in the United States. Am. Med. Writ. Assoc. J. 23, 106-109 (2008).
4. Pines, W. L. A history and perspective on direct-to-consumer promotion. Food Drug Law J. 54, 489-518 (1999).
5. Mintzes, B. Direct to consumer advertising is medicalising normal human experience. BMJ 324, 908-911 (2002).
6. Saul, S. Senate leader calls for limits on drug ads. The New York Times Politics (2 July 2005).
7. Kahneman, D. & Tversky, A. On the psychology of prediction. Psychol. Rev. 80, 237-251 (1973).
8. Nisbett, R. E., Zukier, H. & Lemley, R. E. The dilution effect: nondiagnostic information weakens the implications of diagnostic information. Cognit. Psychol. 13, 248-277 (1981).
9. Zukier, H. Situational determinants of behavior. Soc. Res. 49, 1073-1091 (1982).
10. Zukier, H. & Jennings, D. L. Nondiagnosticity and typicality effects in prediction. Soc. Cogn. 2, 187-198 (1984).
11. Meyvis, T. & Janiszewski, C. Consumers' beliefs about product benefits: the effect of obviously irrelevant product information. J. Consum. Res. 28, 618-635 (2002).
12. Troutman, C. M. & Shanteau, J. Inferences based on nondiagnostic information. Organ. Behav. Hum. Perform. 19, 43-55 (1977).
13. Anderson, N. H. Integration theory and attitude change. Psychol. Rev. 78, 171-206 (1971).
14. Anderson, N. H. Application of an additive model to impression formation. Science 138, 817-818 (1962).
15. Biegler, P. & Vargas, P. Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising. Am. J. Bioeth. 13, 3-13 (2013).
16. Petty, R. E. & Cacioppo, J. T. Communication and Persuasion 1-24 (Springer, New York, 1986); https://doi.org/10.1007/978-1-4612-4964-1-1
17. Zhao, X., Lynch, J. G. & Chen, Q. Reconsidering Baron and Kenny: myths and truths about mediation analysis. J. Consum. Res. 37, 197-206 (2010).
18. MacKinnon, D. P., Krull, J. L. & Lockwood, C. M. Equivalence of the mediation, confounding and suppression effect. Prev. Sci. 1, 173-181 (2000).
19. Schwartz, L. M. & Woloshin, S. The drug facts box: improving the communication of prescription drug information. Proc. Natl Acad. Sci. USA 110, 14069-14074 (2013).
20. Aikin, K. J., O'Donoghue, A. C., Swasy, J. L. & Sullivan, H. W. Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements. Med. Decis. Mak. 31, E23-E33 (2011).
21. Deese, J. & Kaufman, R. A. Serial effects in recall of unorganized and sequentially organized verbal material. J. Exp. Psychol. 54, 180-187 (1957).
22. Spencer, S. J., Zanna, M. P. & Fong, G. T. Establishing a causal chain: why experiments are often more effective than mediational analyses in examining psychological processes. J. Pers. Soc. Psychol. 89, 845-851 (2005).
23. Relations, A. M. AMA calls for ban on direct to consumer advertising of prescription drugs and medical devices. American Medical Association (17 November 2015); http://www.ama-assn.org/ama/pub/news/news/2015/2015-11-17-ban-consumer-prescription-drug-advertising.page
24. Thaler, R. H. & Sunstein, C. R. Libertarian paternalism. Am. Econ. Rev. 93, 175-179 (2003).
25. Daft, R. L. & Lengel, R. H. organizational information requirements, media richness and structural design. Manag. Sci. 32, 554-571 (1986).